ArticleJournal of gastroenterology2013

Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients.

Masataka Tsuge et al.PubMed ↗Publisher ↗

No numbers read from the abstract.